Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: MOBoxy: MoblO2 to Maintain Oxygenation [NA]
This clinical trial update describes a study of MOBoxy (MoblO2) intended to maintain oxygenation in patients with COPD and interstitial lung…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Dorothy P. and Richard P. Simmons Center for ILD Research Registry
This entry describes the Simmons Center ILD Research Registry, a registry for interstitial lung disease, which is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
A real-world, completed evaluation of nintedanib for changes in cough and dyspnea in patients with chronic fibrosing interstitial lung disea…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) [Phase 2]
Phase 2 safety and efficacy trial of tulisokibart (MK-7240/PRA023) for diffuse cutaneous systemic sclerosis-associated interstitial lung dis…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis [Phase 2]
Phase 2 clinical trial evaluating autologous stem cell transplantation in systemic sclerosis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Treatable Traits in Interstitial Lung Disease [NA]
An update indicating that the study on treatable traits in interstitial lung disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different Interstitial Lung Diseases
A clinical trial update describes a study evaluating bronchoalveolar lavage in interstitial lung diseases to characterize specific inflammat…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Evaluation of the Diaphragmatic Index Before and After a Pulmonary Rehabilitation Program in Patients With Interstitial Lung Diseases and Its Impact on Quality of Life [NA]
This clinical trial update describes evaluating the diaphragmatic index before and after a pulmonary rehabilitation program in patients with…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Sputum Cytometry Guided Management for the Elimination of Chronic Cough in Patients With ILD [NA]
McMaster University is recruiting for a trial evaluating sputum cytometry-guided management to eliminate chronic cough in patients with inte…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Interstitial Lung Disease Research Unit Biobank
A clinical trial update for an Interstitial Lung Disease Research Unit Biobank at University of Kansas Medical Center; the study is currentl…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
A clinical trial update announcing a prospective phenotyping and multi-omic endotyping study of progressive pulmonary fibrosis. The study is…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease [NA]
A clinical trial update indicates that NCT03485378, investigating precision irradiation for early non-small cell lung cancer and interstitia…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
This clinical trial aims to characterize radiologic features of rheumatoid arthritis-associated interstitial lung disease on chest high-reso…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea [NA]
A clinical trial entry describes a hypnosis-based breathlessness mastery program for persistent dyspnea in patients with cancer, COPD, inter…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease [Phase 2]
A Phase 2 clinical trial evaluating senicapoc in patients with worsening fibrotic interstitial lung disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Prognostic Score Comparison in IPF and HP
A completed clinical trial compares prognostic scoring methods in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis (interstiti…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Impact of Lung Boost Device on Ventilatory Functions and Fatigue in Patients With Interstitial Lung Diseases [NA]
This clinical trial update reports on the impact of a Lung Boost device on ventilatory function and fatigue in patients with interstitial lu…
-
EMA approval · 2025-09-05EMA Authorised: Nintedanib Viatris (nintedanib) — Viatris Limited
The European Medicines Agency authorised a generic version of nintedanib (Nintedanib Viatris) for idiopathic pulmonary fibrosis and related …
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Ultrasound and Respiratory Physiological Signals in Lung Diseases [NA]
This clinical trial update indicates a recruiting study evaluating ultrasound and respiratory physiological signals in lung diseases. Condit…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung Disease [NA]
This clinical trial update describes tolerability and safety data for nintedanib in patients with myositis-associated interstitial lung dise…
-
EMA approval · 2025-08-29EMA Authorised: Nintedanib Accord (nintedanib) — Accord Healthcare S.L.U.
The EMA authorised Nintedanib Accord for indications including Idiopathic Pulmonary Fibrosis, interstitial lung diseases, systemic sclerosis…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Role of Lung Ultrasound in Screening for Interstitial Lung Disease in Patients With Rheumatoid Arthritis
A completed clinical trial evaluated lung ultrasound as a screening tool for interstitial lung disease in patients with rheumatoid arthritis…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Interstitial Lung Disease is a Risk Factor for Cardiovascular Disease
A completed clinical trial update examining whether interstitial lung disease is a risk factor for cardiovascular disease.
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
A clinical trial evaluating novel biomarkers for assessing interstitial lung disease in rheumatoid arthritis patients; currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Assessment of Diaphragmatic Mobility in Dyspneic Patients With Different Types of Interstitial Lung Diseases
This clinical trial update reports the completion of a study assessing diaphragmatic mobility in dyspneic patients across different types of…